ArticleProceedings of the National Academy of Sciences of the United States of America2025

CRISPR screens identify the ATPase VCP as a druggable therapeutic vulnerability in cholangiocarcinoma.

Wu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.